Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amorphous silibinin for the treatment of viral hepatitis

Amorphous silibinin for the treatment of viral hepatitis

US Patent 8614341 · Granted Dec 24, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FYN and VEGFR2 kinase inhibitors2025
(R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyc2025
Process for the preparation of (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspir2025
(R)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-be2023
Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors2023
FYN kinase inhibitors2018
Anti-ADAMTS-5 antibody, derivatives and uses thereof2017
Spiro aminic compounds with NK1 antagonist activity2016
Anti-TrkA antibodies, derivatives and uses thereof2016
Silibinin component for the treatment of hepatitis2016
Silibinin component for the treatment of hepatitis2016
Silibinin component for the treatment of hepatitis2016